Fundraising Fox
Neuro42
San Francisco, US · Founded 2020 · Delaware corporation · 3 known investors
Find your way into Neuro42
Sign up to see every warm intro you have to Neuro42
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuro42 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.
Founders & leadership
Neuro42 was founded in 2020 by Amit Vohra.
Board
Investors · 3
How we know: Frontier Path VC's portfolio page · Not right? Tell us
How we know: ShangBay Capital LLC's portfolio page · funding news · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$22.2M disclosed across 2 rounds · 2024
▶$15.6MraisedSep 2024 · 85 investors · Other Health CareRule 506(b)
- Krishna R. BhupalDirector
- Amit VohraExecutive Officer, Director
- Rahul TalwarDirector
- Abhita BatraExecutive Officer, Director
- Offering amount
- $36.6M
- Amount sold
- $15.6M
- Minimum investment
- $1
- First sale
- Sep 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$6.7MraisedJun 2024 · 24 investors · Other Health CareRule 506(b)
- Krishna R. BhupalDirector
- Abhita BatraExecutive Officer, Director
- Amit VohraExecutive Officer, Director
- Shibu GangadharanExecutive Officer
- Offering amount
- $7.3M
- Amount sold
- $6.7M
- Minimum investment
- $1
- First sale
- May 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
3 people who came through Neuro42 went on to found or lead other companies.
+ 1 more
Related companies · 2
Companies working in the same space as Neuro42.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2023 | $484.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Neuro42 do?
- neuro42 develops a portable, FDA 510(k)-cleared MRI platform that brings neurological imaging directly to the patient rather than requiring transport to a facility. The system supports point-of-care diagnosis and image-guided, minimally invasive neurological procedures for physicians and patients.
- Who founded Neuro42?
- Neuro42 was founded by Amit Vohra in 2020.
- Who are Neuro42's investors?
- Neuro42's investors include Frontier Path VC, ShangBay Capital LLC, Sonder Capital.
- How much funding has Neuro42 raised?
- Neuro42 has disclosed $22.2M raised across 2 rounds.
- Where is Neuro42 headquartered?
- Neuro42 is headquartered in San Francisco, US.